CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease

Details for Australian Patent Application No. 2012203599 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Harriman, Geraldine C. B.; Carson, Kenneth G.; Ghosh, Shomir

Agent Davies Collison Cave

Pub. Number AU-A-2012203599

Parent 2008202965

Filing date 20 June 2012

Wipo publication date 12 July 2012

International Classifications

C07D 491/04 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

5 July 2012 Complete Application Filed

12 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203599

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203600-Reconstituting infusion device

2012203598-Electrode for use with double electric layer electrochemical capacitors having high specific parameters